Rocuronium ( DrugBank: Rocuronium )
2 diseases
| 告示番号 | 疾患名（ページ内リンク） | 臨床試験数 |
|---|---|---|
| 70 | 広範脊柱管狭窄症 | 1 |
| 296 | 胆道閉鎖症 | 1 |
70. 広範脊柱管狭窄症
臨床試験数 : 95 / 薬物数 : 169 - (DrugBank : 61) / 標的遺伝子数 : 68 - 標的パスウェイ数 : 90
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT05619848 (ClinicalTrials.gov) | October 25, 2022 | 9/11/2022 | Effect of Paravertebral Muscle Fat Infiltration on Rocuronium Use in Lumbar Surgery | Effect of Paravertebral Muscle Fat Infiltration on Rocuronium Use in Lumbar Surgery | Spinal Stenosis Lumbar | Drug: Rocuronium Bromide | Zheng Guo | NULL | Completed | 18 Years | 65 Years | All | 87 | Early Phase 1 | China |
296. 胆道閉鎖症
臨床試験数 : 71 / 薬物数 : 70 - (DrugBank : 39) / 標的遺伝子数 : 35 - 標的パスウェイ数 : 60
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ChiCTR-OOC-16008707 | 2016-06-01 | 2016-06-22 | Study on pharmacodynamics of continuous infusion of rocuronium during transplantation of living donor liver transplantation for infants | Study on pharmacodynamics of continuous infusion of rocuronium during transplantation of living donor liver transplantation for infants | congenital biliary atresia | obstructive jaundice group:continuous infusion of rocuronium;after Kasai portoenterostomy group :continuous infusion of rocuronium; | Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University | NULL | Recruiting | Both | obstructive jaundice group:15;after Kasai portoenterostomy group :15; | China |